Validation Of the Tau Heterogeneity Evaluation in Alzheimer’s Disease (THETA) Score Using Longitudinal and Histopathology Data

THETA remained clearly negative or positive in MCI and AD, providing consistent information on underlying etiology of impairment at both baseline and follow-up. Although binary in its construction, THETA both provided separation of values based on tau status and its change correlated with baseline amyloid burden especially in discordant-CU where tau deposition is not in typical meta-ROIs. Further work is needed to confirm if THETA captures early tau changes.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.091770
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation Of the Tau Heterogeneity Evaluation in Alzheimer’s Disease (THETA) Score Using Longitudinal and Histopathology Data

Val J. Lowe, Clifford R. Jack, Alejandro Costoya‐Sánchez, Anthony J. Spychalla et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Validation Of the Tau Heterogeneity Evaluation in Alzheimer’s Disease (THETA) Score Using Longitudinal and Histopathology Data

Val J. Lowe, Clifford R. Jack, Alejandro Costoya‐Sánchez, Anthony J. Spychalla, Jonathan Graff‐Radford, Prashanthi Vemuri, Robel K Gebre, Melissa E. Murray, Sheelakumari Raghavan, David S. Knopman, Christopher G. Schwarz, Fiona Heeman, Alexis Moscoso, Michael Schöll, Ronald C. Petersen, Heather J. Wiste
article en

Abstract

THETA remained clearly negative or positive in MCI and AD, providing consistent information on underlying etiology of impairment at both baseline and follow-up. Although binary in its construction, THETA both provided separation of values based on tau status and its change correlated with baseline amyloid burden especially in discordant-CU where tau deposition is not in typical meta-ROIs. Further work is needed to confirm if THETA captures early tau changes.

Alzheimer s & DementiaVol. 20(S1)
Mayo Clinic (US), Universidade de Santiago de Compostela (ES), WinnMed (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US), University of Gothenburg (SE)
Openalex Percentile: Top 66%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Validation Of the Tau Heterogeneity Evaluation in Alzheimer’s Disease (THETA) Score Using Longitudinal and Histopathology Data — Val J. Lowe, Clifford R. Jack, et al. · Alzheimer s & Dementia (2024) | TGRS Research Map | TGRS